Further, they designed CL-PDT molecules (NTR-CL-E1) based on the CL-E1 core for nitroreductase (NTR) activation to produce 1O2 in specific tumor cell lines (Figure 4C). The gene discussed is NTSR1; the disease is neoplasm.